Define relative incomplete resection by highest mediastinal lymph node metastasis for non-small cell lung cancers: rationale based on prognosis analysis
- PMID: 21075473
- DOI: 10.1016/j.lungcan.2010.10.003
Define relative incomplete resection by highest mediastinal lymph node metastasis for non-small cell lung cancers: rationale based on prognosis analysis
Abstract
Purpose: Present research aimed to explore the rationale of defining RIR operations by metastatic status of highest nodes.
Patients and methods: 549 surgical patients, bearing pN2-NSCLCs, were enrolled in the current study. R1/R2 nodes on the right side and L4 nodes on the left were taken as the highest mediastinal lymph nodes. The operations were defined "Complete Resection (CR)" if the highest nodes were negative. Operations were otherwise "Relative Incomplete Resections (RIR)" if the nodes were positive. Exclusion criteria included: metastatic carcinomas or small cell lung cancer, prior history of induction therapy, exploratory thoracotomy, palliative resection, and massive pleural dissemination, as well as cases without "highest" mediastinal nodal pathology. The survival rate was calculated using the life-table and Kaplan-Meier method. Comparisons between groups were calculated using the Log-rank test.
Results: A total of 6865 lymph nodes (5705 mediastinal and 1160 regional, average 12.6±6.4 nodes for each patient) were removed. Total cases included 246 RIR (100 left and 146 right side) and 303 CR (108 left and 195 right). The overall 5-year survival rate was 22% and the median survival time was 28.29 months. Five-year survival rates of the CR and RIR group were statistically significant (29% and 13%, respectively p<0.0001). L4 and R1/R2 lymph nodes had similar position for defining RIR; no obvious survival difference was indicated between either side (p=0.464 in CR groups, p=0.647 in RIR groups). N2 subcategories and skip-metastasis were closely associated with highest nodal involvement (p<0.0001). Multivariate analysis showed CR/RIR assignment, tumor size, N2 disease stratification, pathological T status, and number of positive mediastinal nodes were risk factors for 5-year survival in the present case series.
Conclusion: Involvement of the highest mediastinal lymph nodes is highly predictive of poor prognosis and indicates an advanced stage of the disease. Therefore, it may be appropriate to assign R1/R2 or L4 as criterion for defining RIR or CR cases in surgical NSCLC cases.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.Ann Thorac Surg. 2008 Jan;85(1):211-5. doi: 10.1016/j.athoracsur.2007.08.020. Ann Thorac Surg. 2008. PMID: 18154813
-
Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.Ann Thorac Surg. 2006 Jan;81(1):292-7. doi: 10.1016/j.athoracsur.2005.06.077. Ann Thorac Surg. 2006. PMID: 16368383
-
Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.Interact Cardiovasc Thorac Surg. 2011 May;12(5):733-8. doi: 10.1510/icvts.2010.249896. Epub 2011 Feb 5. Interact Cardiovasc Thorac Surg. 2011. PMID: 21297135
-
The role of surgery in patients with clinical n2 disease.Thorac Surg Clin. 2013 Aug;23(3):327-35. doi: 10.1016/j.thorsurg.2013.04.007. Epub 2013 Jun 4. Thorac Surg Clin. 2013. PMID: 23931016 Review.
-
Oligometastatic Disease and Local Therapies: A Medical Oncology Perspective.Cancer J. 2020 Mar/Apr;26(2):144-148. doi: 10.1097/PPO.0000000000000439. Cancer J. 2020. PMID: 32205539 Review.
Cited by
-
ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Non-small Cell Lung Cancer Patients.Ann Surg Oncol. 2024 Aug;31(8):5094-5095. doi: 10.1245/s10434-024-15243-7. Epub 2024 Apr 4. Ann Surg Oncol. 2024. PMID: 38573442 No abstract available.
-
The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer.J Cancer Res Clin Oncol. 2023 Nov;149(14):13311-13321. doi: 10.1007/s00432-023-05101-6. Epub 2023 Jul 24. J Cancer Res Clin Oncol. 2023. PMID: 37488397 Free PMC article.
-
The Prognosis According to Patterns of Mediastinal Lymph Node Metastasis in Pathologic Stage IIIA/N2 Non-Small Cell Lung Cancer.Korean J Thorac Cardiovasc Surg. 2014 Feb;47(1):13-9. doi: 10.5090/kjtcs.2014.47.1.13. Epub 2014 Feb 5. Korean J Thorac Cardiovasc Surg. 2014. PMID: 24570860 Free PMC article.
-
Prognostic significance of uncertain resection for metastasis in the highest mediastinal lymph node after surgery for clinical N0 non-small cell lung cancer.Front Surg. 2023 Jun 15;10:1115696. doi: 10.3389/fsurg.2023.1115696. eCollection 2023. Front Surg. 2023. PMID: 37396297 Free PMC article.
-
Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.Med Oncol. 2012 Dec;29(5):3190-7. doi: 10.1007/s12032-012-0303-z. Epub 2012 Jul 11. Med Oncol. 2012. PMID: 22782668
MeSH terms
LinkOut - more resources
Full Text Sources
Medical